Latest News and Press Releases
Want to stay updated on the latest news?
-
Press release Synairgen plc(‘Synairgen’ or the ‘Company’) Synairgen announces data from Home Cohort of SG016 Phase II trial of inhaled interferon beta in COVID-19 patients and encouraging...
-
Press release Synairgen plc(‘Synairgen’ or the ‘Company’) Synairgen announces that dosing has commenced with its inhaled interferon beta product in US...
-
Press release Synairgen plc(‘Synairgen’ or the ‘Company’) Synairgen announces that dosing has commenced with its inhaled interferon beta product in US...
-
Press release Synairgen plc(‘Synairgen’ or the ‘Company’) Synairgen announces inclusion of its inhaled interferon beta treatment in US NIH ACTIV-2 trial in COVID-19 outpatients ACTIV partnership is...
-
Press release Synairgen plc(‘Synairgen’ or the ‘Company’) Synairgen announces inclusion of its inhaled interferon beta treatment in US NIH ACTIV-2 trial in COVID-19 outpatients ACTIV partnership is...
-
Press release Synairgen plc(‘Synairgen’ or the ‘Company’) Synairgen announces completion of recruitment into its Phase II Home-Based COVID-19 study of inhaled interferon beta - Establishing proof...
-
Press release Synairgen plc(‘Synairgen’ or the ‘Company’) Synairgen announces completion of recruitment into its Phase II Home-Based COVID-19 study of inhaled interferon beta - Establishing proof...
-
Press release Synairgen plc(‘Synairgen’ or the ‘Company’) Synairgen announces commencement of dosing in its international Phase III study of inhaled interferon beta in hospitalised COVID-19 patients...
-
Press release Synairgen plc(‘Synairgen’ or the ‘Company’) Synairgen announces commencement of dosing in its international Phase III study of inhaled interferon beta in hospitalised COVID-19 patients...
-
Press release Synairgen plc(‘Synairgen’ or the ‘Company’) COVID-19 Clinical Programme Update SNG001 given Fast Track designation and IND cleared by the US FDAPhase III trial design adapted which...